dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate mylan
mylan ireland limited - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multippel sklerose, relapsing-remitting - immunsuppressive - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
dimethyl fumarate teva
teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressive - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
methylphenidate teva 60 mg
teva b.v. - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 60 mg
methylphenidate teva 10 mg
teva b.v. - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 10 mg
methylphenidate teva 20 mg
teva b.v. - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 20 mg
methylphenidate teva 30 mg
teva b.v. - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 30 mg
methylphenidate teva 40 mg
teva b.v. - metylfenidathydroklorid - kapsel med modifisert frisetting, hard - 40 mg